EBR SystemsEBRCZ -1.90%22 Net Margin % is -722.86% as of Mar. 2026. GuruFocus rates EBRCZ with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, EBR Systems ranks worse than 94.12% on this metric.
Net margin is calculated as Net Income divided by its Revenue. EBR Systems's Net Income for the
three
months ended in Mar. 2026 was $-17.07 Mil. EBR Systems's Revenue for the
three
months ended in Mar. 2026 was $2.36 Mil. Therefore, EBR Systems's net margin for the quarter that ended in Mar. 2026 was -722.86%.
The historical rank and industry rank for EBR Systems's Net Margin % or its related term are showing as below:
EBRCZ'
s Net Margin % Range Over the Past 10 Years
Min: -3015.34 Med: -3015.34 Max: -1389.22
Current: -1389.22
EBRCZ's Net Margin % is ranked worse than 94.12% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs EBRCZ: -1389.22
EBR Systems (OTCPK:EBRCZ) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
EBR Systems Net Margin % Related Terms
EBR Systems Net Margin % Historical Data
* Premium members only.
The historical data trend for EBR Systems's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBRCZ vs CVRX, QTRX, SNWV: Net Margin % Comparison
For the Medical Devices subindustry, EBR Systems's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EBR Systems Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EBR Systems's Net Margin % distribution charts can be found below:
* The bar in red indicates where EBR Systems's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBR Systems (EBRCZ) has a Net Margin % of -722.86% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on EBR Systems and its competitors. According to the industry distribution chart, EBR Systems ranks #769 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 94.1%.
Is EBR Systems' Net Margin % too high?
EBR Systems' current Net Margin % is -722.86%. Based on the distribution chart, EBR Systems ranks #769 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, EBR Systems has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does EBR Systems' Net Margin % compare to CVRX and QTRX?
According to the Medical Devices & Instruments industry distribution chart, EBR Systems ranks #769 out of 817 companies for Net Margin %. This places EBR Systems in the lower half of its industry. The industry median Net Margin % is 2.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on EBR Systems and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBR Systems's current Net Margin % is -722.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBR Systems stock overvalued right now?
EBR Systems (EBRCZ) has a current Net Margin % of -722.86%. The current Net Margin % is -722.86%. EBR Systems' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For EBR Systems (EBRCZ), the current Net Margin % is -722.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EBR Systems Inc is engaged in treatment for patients suffering from cardiac rhythm diseases by developing therapies using wireless cardiac stimulation. The company's Wise CRT System uses proprietary wireless technology to deliver pacing stimulation directly inside the left ventricle of the heart. It conducts its operations in the United States.
22GF Score
Get the complete analysis for EBRCZ
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EBRCZ has been successfully added to your 
